{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:10:32Z","timestamp":1791857432329,"version":"4.3.4"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T00:00:00Z","timestamp":1323129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/mp.2011.165","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T04:14:54Z","timestamp":1323144894000},"page":"389-401","source":"Crossref","is-referenced-by-count":462,"title":["A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures"],"prefix":"10.1038","volume":"17","author":[{"given":"D A","family":"Rossignol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"BFmp2011165_CR1","unstructured":"APA. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 1994."},{"key":"BFmp2011165_CR2","first-page":"1","volume":"58","author":"C Rice","year":"2009","unstructured":"Rice C . Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009; 58: 1\u201320.","journal-title":"MMWR Surveill Summ"},{"key":"BFmp2011165_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/GIM.0b013e31815efdd7","volume":"10","author":"GB Schaefer","year":"2008","unstructured":"Schaefer GB, Mendelsohn NJ . Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet Med 2008; 10: 4\u201312.","journal-title":"Genet Med"},{"key":"BFmp2011165_CR4","doi-asserted-by":"crossref","unstructured":"Rossignol DA, Frye RE . Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 2011.","DOI":"10.1038\/mp.2010.136"},{"issue":"Suppl 1","key":"BFmp2011165_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1542\/peds.2009-1878C","volume":"125","author":"T Buie","year":"2010","unstructured":"Buie T, Campbell DB, Fuchs III GJ, Furuta GT, Levy J, Vandewater J et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010; 125 (Suppl 1): S1\u201318.","journal-title":"Pediatrics"},{"key":"BFmp2011165_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/ajmg.b.30366","volume":"141","author":"SJ James","year":"2006","unstructured":"James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 947\u2013956.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFmp2011165_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","volume":"25","author":"P Ashwood","year":"2010","unstructured":"Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J . Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2010; 25: 40\u201345.","journal-title":"Brain Behav Immun"},{"key":"BFmp2011165_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0883073807307102","volume":"23","author":"X Ming","year":"2008","unstructured":"Ming X, Brimacombe M, Chaaban J, Zimmerman-Bier B, Wagner GC . Autism spectrum disorders: concurrent clinical disorders. J Child Neurol 2008; 23: 6\u201313.","journal-title":"J Child Neurol"},{"key":"BFmp2011165_CR9","first-page":"354","volume":"2","author":"MR Herbert","year":"2005","unstructured":"Herbert MR . Autism: a brain disorder or a disorder that affects the brain. Clinical Neuropsychiatry 2005; 2: 354\u2013379.","journal-title":"Clinical Neuropsychiatry"},{"key":"BFmp2011165_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","volume":"10","author":"PJ Harrison","year":"2005","unstructured":"Harrison PJ, Weinberger DR . Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40\u201368;, image 45.","journal-title":"Mol Psychiatry"},{"key":"BFmp2011165_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biopsych.2010.10.032","volume":"69","author":"JE Kleinman","year":"2011","unstructured":"Kleinman JE, Law AJ, Lipska BK, Hyde TM, Ellis JK, Harrison PJ et al. Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry 2011; 69: 140\u2013145.","journal-title":"Biol Psychiatry"},{"key":"BFmp2011165_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/07853890801923753","volume":"40","author":"L Shao","year":"2008","unstructured":"Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM et al. Mitochondrial involvement in psychiatric disorders. Ann Med 2008; 40: 281\u2013295.","journal-title":"Ann Med"},{"key":"BFmp2011165_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1461145707008401","volume":"11","author":"F Ng","year":"2008","unstructured":"Ng F, Berk M, Dean O, Bush AI . Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008; 11: 1\u201326.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp2011165_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW . From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"BFmp2011165_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3810\/pgm.2011.01.2256","volume":"123","author":"MG Burke","year":"2011","unstructured":"Burke MG, Miller MD . Practical guidelines for evaluating lead exposure in children with mental health conditions: molecular effects and clinical implications. Postgrad Med 2011; 123: 160\u2013168.","journal-title":"Postgrad Med"},{"key":"BFmp2011165_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit WJ, Mrak RE, Griffin WS . Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 2004; 1: 14.","journal-title":"J Neuroinflammation"},{"key":"BFmp2011165_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/glia.10146","volume":"40","author":"P Eikelenboom","year":"2002","unstructured":"Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002; 40: 232\u2013239.","journal-title":"Glia"},{"key":"BFmp2011165_CR18","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","volume":"50","author":"J Doorduin","year":"2009","unstructured":"Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC . Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 2009; 50: 1801\u20131807.","journal-title":"J Nucl Med"},{"key":"BFmp2011165_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/mp.2009.47","volume":"15","author":"JS Rao","year":"2010","unstructured":"Rao JS, Harry GJ, Rapoport SI, Kim HW . Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2010; 15: 384\u2013392.","journal-title":"Mol Psychiatry"},{"key":"BFmp2011165_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.biopsych.2010.01.023","volume":"67","author":"N Dobos","year":"2010","unstructured":"Dobos N, Korf J, Luiten PG, Eisel UL . Neuroinflammation in Alzheimer's disease and major depression. Biol Psychiatry 2010; 67: 503\u2013504.","journal-title":"Biol Psychiatry"},{"key":"BFmp2011165_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/02646830500381930","volume":"17","author":"CA Pardo","year":"2005","unstructured":"Pardo CA, Vargas DL, Zimmerman AW . Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005; 17: 485\u2013495.","journal-title":"Int Rev Psychiatry"},{"key":"BFmp2011165_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","volume":"207","author":"X Li","year":"2009","unstructured":"Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009; 207: 111\u2013116.","journal-title":"J Neuroimmunol"},{"key":"BFmp2011165_CR23","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1371\/journal.pbio.0050035","volume":"5","author":"Z Li","year":"2007","unstructured":"Li Z, Dong T, Proschel C, Noble M . Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function. PLoS Biol 2007; 5: e35.","journal-title":"PLoS Biol"},{"key":"BFmp2011165_CR24","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/S0140-6736(06)69665-7","volume":"368","author":"P Grandjean","year":"2006","unstructured":"Grandjean P, Landrigan PJ . Developmental neurotoxicity of industrial chemicals. Lancet 2006; 368: 2167\u20132178.","journal-title":"Lancet"},{"key":"BFmp2011165_CR25","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1289\/ehp.9478","volume":"114","author":"JM Braun","year":"2006","unstructured":"Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP . Exposures to environmental toxicants and attention deficit hyperactivity disorder in US children. Environ Health Perspect 2006; 114: 1904\u20131909.","journal-title":"Environ Health Perspect"},{"key":"BFmp2011165_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.biopsych.2007.07.013","volume":"63","author":"JT Nigg","year":"2008","unstructured":"Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W et al. Low blood lead levels associated with clinically diagnosed attention-deficit\/hyperactivity disorder and mediated by weak cognitive control. Biol Psychiatry 2008; 63: 325\u2013331.","journal-title":"Biol Psychiatry"},{"key":"BFmp2011165_CR27","doi-asserted-by":"publisher","first-page":"e1270","DOI":"10.1542\/peds.2009-3058","volume":"125","author":"MF Bouchard","year":"2010","unstructured":"Bouchard MF, Bellinger DC, Wright RO, Weisskopf MG . Attention-deficit\/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics 2010; 125: e1270\u2013e1277.","journal-title":"Pediatrics"},{"key":"BFmp2011165_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/enrs.1997.3744","volume":"73","author":"MM Amr","year":"1997","unstructured":"Amr MM, Halim ZS, Moussa SS . Psychiatric disorders among Egyptian pesticide applicators and formulators. Environ Res 1997; 73: 193\u2013199.","journal-title":"Environ Res"},{"key":"BFmp2011165_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1289\/ehp.6777","volume":"112","author":"MG Opler","year":"2004","unstructured":"Opler MG, Brown AS, Graziano J, Desai M, Zheng W, Schaefer C et al. Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. Environ Health Perspect 2004; 112: 548\u2013552.","journal-title":"Environ Health Perspect"},{"key":"BFmp2011165_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.healthplace.2008.02.001","volume":"15","author":"RF Palmer","year":"2009","unstructured":"Palmer RF, Blanchard S, Wood R . Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 2009; 15: 18\u201324.","journal-title":"Health Place"},{"key":"BFmp2011165_CR31","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1289\/ehp.9120","volume":"114","author":"GC Windham","year":"2006","unstructured":"Windham GC, Zhang L, Gunier R, Croen LA, Grether JK . Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco bay area. Environ Health Perspect 2006; 114: 1438\u20131444.","journal-title":"Environ Health Perspect"},{"key":"BFmp2011165_CR32","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1289\/ehp.10168","volume":"115","author":"EM Roberts","year":"2007","unstructured":"Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C . Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 2007; 115: 1482\u20131489.","journal-title":"Environ Health Perspect"},{"key":"BFmp2011165_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/00004872-200018060-00002","volume":"18","author":"NS Dhalla","year":"2000","unstructured":"Dhalla NS, Temsah RM, Netticadan T . Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655\u2013673.","journal-title":"J Hypertens"},{"key":"BFmp2011165_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jbt.10058","volume":"17","author":"AC Maritim","year":"2003","unstructured":"Maritim AC, Sanders RA, Watkins III JB . Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24\u201338.","journal-title":"J Biochem Mol Toxicol"},{"key":"BFmp2011165_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1081\/CEH-200031904","volume":"26","author":"J de Champlain","year":"2004","unstructured":"de Champlain J, Wu R, Girouard H, Karas M, EL Midaoui A, Laplante MA et al. Oxidative stress in hypertension. Clin Exp Hypertens 2004; 26: 593\u2013601.","journal-title":"Clin Exp Hypertens"},{"key":"BFmp2011165_CR36","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.mp.4001511","volume":"9","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 643 684\u2013697.","journal-title":"Mol Psychiatry"},{"key":"BFmp2011165_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1086\/507566","volume":"79","author":"M Tosic","year":"2006","unstructured":"Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F et al. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 2006; 79: 586\u2013592.","journal-title":"Am J Hum Genet"},{"key":"BFmp2011165_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","volume":"19","author":"ME Ozcan","year":"2004","unstructured":"Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O . Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004; 19: 89\u201395.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFmp2011165_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","volume":"111","author":"AC Andreazza","year":"2008","unstructured":"Andreazza AC, Kauer-Sant\u2019anna M, Frey BN, Bond DJ, Kapczinski F, Young LT et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008; 111: 135\u2013144.","journal-title":"J Affect Disord"},{"key":"BFmp2011165_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pnpbp.2006.06.011","volume":"31","author":"BN Frey","year":"2007","unstructured":"Frey BN, Andreazza AC, Kunz M, Gomes FA, Quevedo J, Salvador M et al. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 283\u2013285.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp2011165_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","volume":"58","author":"J Emerit","year":"2004","unstructured":"Emerit J, Edeas M, Bricaire F . Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004; 58: 39\u201346.","journal-title":"Biomed Pharmacother"},{"key":"BFmp2011165_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"A Chauhan","year":"2006","unstructured":"Chauhan A, Chauhan V . Oxidative stress in autism. Pathophysiology 2006; 13: 171\u2013181.","journal-title":"Pathophysiology"},{"key":"BFmp2011165_CR43","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1542\/peds.2007-0391","volume":"120","author":"RH Haas","year":"2007","unstructured":"Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N et al. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007; 120: 1326\u20131333.","journal-title":"Pediatrics"},{"key":"BFmp2011165_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijdevneu.2010.08.007","volume":"29","author":"HB Clay","year":"2011","unstructured":"Clay HB, Sillivan S, Konradi C . Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011; 29: 311\u2013324.","journal-title":"Int J Dev Neurosci"},{"key":"BFmp2011165_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neures.2010.12.013","volume":"69","author":"M Kato","year":"2011","unstructured":"Kato M, Nakamura M, Ichiba M, Tomiyasu A, Shimo H, Higuchi I et al. Mitochondrial DNA deletion mutations in patients with neuropsychiatric symptoms. Neurosci Res 2011; 69: 331\u2013336.","journal-title":"Neurosci Res"},{"key":"BFmp2011165_CR46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ddrr.115","volume":"16","author":"F Scaglia","year":"2010","unstructured":"Scaglia F . The role of mitochondrial dysfunction in psychiatric disease. Dev Disabil Res Rev 2010; 16: 136\u2013143.","journal-title":"Dev Disabil Res Rev"},{"key":"BFmp2011165_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.eurpsy.2010.08.008","volume":"26","author":"B Verge","year":"2011","unstructured":"Verge B, Alonso Y, Valero J, Miralles C, Vilella E, Martorell L . Mitochondrial DNA (mtDNA) and schizophrenia. Eur Psychiatry 2011; 26: 45\u201356.","journal-title":"Eur Psychiatry"},{"key":"BFmp2011165_CR48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3844\/ajbbsp.2008.208.217","volume":"4","author":"DA Rossignol","year":"2008","unstructured":"Rossignol DA, Bradstreet JJ . Evidence of mitochondrial dysfunction in autism and implications for treatment. Am J Biochem Biotech 2008; 4: 208\u2013217.","journal-title":"Am J Biochem Biotech"},{"issue":"5 Part 2","key":"BFmp2011165_CR49","doi-asserted-by":"publisher","first-page":"41R","DOI":"10.1203\/PDR.0b013e318212f16b","volume":"69","author":"RE Frye","year":"2011","unstructured":"Frye RE, Rossignol DA . Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res 2011; 69 (5 Part 2): 41R\u201347R.","journal-title":"Pediatr Res"},{"key":"BFmp2011165_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3844\/ajbbsp.2008.167.176","volume":"4","author":"MP Anderson","year":"2008","unstructured":"Anderson MP, Hooker BS, Herbert MR . Bridging from cells to cognition in autism pathophysiology: biological pathways to defective brain function and plasticity. Am J Biochem Biotech 2008; 4: 167\u2013176.","journal-title":"Am J Biochem Biotech"},{"key":"BFmp2011165_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfp179","volume":"112","author":"RA Roberts","year":"2009","unstructured":"Roberts RA, Laskin DL, Smith CV, Robertson FM, Allen EM, Doorn JA et al. Nitrative and oxidative stress in toxicology and disease. Toxicol Sci 2009; 112: 4\u201316.","journal-title":"Toxicol Sci"},{"key":"BFmp2011165_CR52","unstructured":"The Oxford 2011 Levels of Evidence. http:\/\/www.cebm.net\/index.aspx?o=5653 , (accessed 2011)."},{"key":"BFmp2011165_CR53","first-page":"221","volume":"20","author":"I Sterzl","year":"1999","unstructured":"Sterzl I, Prochazkova J, Hrda P, Bartova J, Matucha P, Stejskal VD . Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuro Endocrinol Lett 1999; 20: 221\u2013228.","journal-title":"Neuro Endocrinol Lett"},{"key":"BFmp2011165_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-2094-7-20","volume":"7","author":"D Kempuraj","year":"2010","unstructured":"Kempuraj D, Asadi S, Zhang B, Manola A, Hogan J, Peterson E et al. Mercury induces inflammatory mediator release from human mast cells. J Neuroinflammation 2010; 7: 20.","journal-title":"J Neuroinflammation"},{"key":"BFmp2011165_CR55","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1080\/01926230490520232","volume":"32","author":"L Calderon-Garciduenas","year":"2004","unstructured":"Calderon-Garciduenas L, Reed W, Maronpot RR, Henriquez-Roldan C, Delgado-Chavez R, Calderon-Garciduenas A et al. Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicol Pathol 2004; 32: 650\u2013658.","journal-title":"Toxicol Pathol"},{"key":"BFmp2011165_CR56","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.autrev.2004.12.001","volume":"4","author":"S Havarinasab","year":"2005","unstructured":"Havarinasab S, Hultman P . Organic mercury compounds and autoimmunity. Autoimmun Rev 2005; 4: 270\u2013275.","journal-title":"Autoimmun Rev"},{"key":"BFmp2011165_CR57","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0192623307313011","volume":"36","author":"L Calderon-Garciduenas","year":"2008","unstructured":"Calderon-Garciduenas L, Solt AC, Henriquez-Roldan C, Torres-Jardon R, Nuse B, Herritt L et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol Pathol 2008; 36: 289\u2013310.","journal-title":"Toxicol Pathol"},{"key":"BFmp2011165_CR58","first-page":"17","volume":"17","author":"S Yee","year":"1996","unstructured":"Yee S, Choi BH . Oxidative stress in neurotoxic effects of methylmercury poisoning. Neurotoxicology 1996; 17: 17\u201326.","journal-title":"Neurotoxicology"},{"key":"BFmp2011165_CR59","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1046\/j.1440-1681.1999.03157.x","volume":"26","author":"SJ Flora","year":"1999","unstructured":"Flora SJ . Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin Exp Pharmacol Physiol 1999; 26: 865\u2013869.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFmp2011165_CR60","first-page":"OL543","volume":"50","author":"SJ Flora","year":"2004","unstructured":"Flora SJ, Pande M, Kannan GM, Mehta A . Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats. Cell Mol Biol 2004; 50: OL543\u2013OL551.","journal-title":"Cell Mol Biol"},{"key":"BFmp2011165_CR61","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.4049\/jimmunol.163.10.5582","volume":"163","author":"TS Hiura","year":"1999","unstructured":"Hiura TS, Kaszubowski MP, Li N, Nel AE . Chemicals in diesel exhaust particles generate reactive oxygen radicals and induce apoptosis in macrophages. J Immunol 1999; 163: 5582\u20135591.","journal-title":"J Immunol"},{"key":"BFmp2011165_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10565-006-0135-8","volume":"23","author":"S Bhadauria","year":"2007","unstructured":"Bhadauria S, Flora SJ . Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats. Cell Biol Toxicol 2007; 23: 91\u2013104.","journal-title":"Cell Biol Toxicol"},{"key":"BFmp2011165_CR63","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1159\/000107546","volume":"20","author":"R Mailloux","year":"2007","unstructured":"Mailloux R, Lemire J, Appanna V . Aluminum-induced mitochondrial dysfunction leads to lipid accumulation in human hepatocytes: a link to obesity. Cell Physiol Biochem 2007; 20: 627\u2013638.","journal-title":"Cell Physiol Biochem"},{"key":"BFmp2011165_CR64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0014-4800(77)90010-7","volume":"27","author":"BA Fowler","year":"1977","unstructured":"Fowler BA, Woods JS . Ultrastructural and biochemical changes in renal mitochondria during chronic oral methyl mercury exposure: the relationship to renal function. Exp Mol Pathol 1977; 27: 403\u2013412.","journal-title":"Exp Mol Pathol"},{"key":"BFmp2011165_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/taap.1999.8652","volume":"157","author":"BJ Shenker","year":"1999","unstructured":"Shenker BJ, Guo TL, O I, Shapiro IM . Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol 1999; 157: 23\u201335.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFmp2011165_CR66","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.nutr.17.1.37","volume":"17","author":"RA Goyer","year":"1997","unstructured":"Goyer RA . Toxic and essential metal interactions. Annu Rev Nutr 1997; 17: 37\u201350.","journal-title":"Annu Rev Nutr"},{"key":"BFmp2011165_CR67","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4615-0667-6_38","volume":"500","author":"J Pourahmad","year":"2001","unstructured":"Pourahmad J, Mihajlovic A, O\u2019Brien PJ . Hepatocyte lysis induced by environmental metal toxins may involve apoptotic death signals initiated by mitochondrial injury. Adv Exp Med Biol 2001; 500: 249\u2013252.","journal-title":"Adv Exp Med Biol"},{"key":"BFmp2011165_CR68","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1046\/j.1471-4159.2001.00022.x","volume":"76","author":"PW Wong","year":"2001","unstructured":"Wong PW, Garcia EF, Pessah IN . ortho-substituted PCB95 alters intracellular calcium signaling and causes cellular acidification in PC12 cells by an immunophilin-dependent mechanism. J Neurochem 2001; 76: 450\u2013463.","journal-title":"J Neurochem"},{"key":"BFmp2011165_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00213961","volume":"28","author":"T Yamano","year":"1995","unstructured":"Yamano T, Morita S . Effects of pesticides on isolated rat hepatocytes, mitochondria, and microsomes II. Arch Environ Contam Toxicol 1995; 28: 1\u20137.","journal-title":"Arch Environ Contam Toxicol"},{"key":"BFmp2011165_CR70","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/00004583-199508000-00022","volume":"34","author":"GA Stefanatos","year":"1995","unstructured":"Stefanatos GA, Grover W, Geller E . Case study: corticosteroid treatment of language regression in pervasive developmental disorder. J Am Acad Child Adolesc Psychiatry 1995; 34: 1107\u20131111.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFmp2011165_CR71","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF02178503","volume":"25","author":"H Komori","year":"1995","unstructured":"Komori H, Matsuishi T, Yamada S, Yamashita Y, Ohtaki E, Kato H . Cerebrospinal fluid biopterin and biogenic amine metabolites during oral R-THBP therapy for infantile autism. J Autism Dev Disord 1995; 25: 183\u2013193.","journal-title":"J Autism Dev Disord"},{"key":"BFmp2011165_CR72","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3945\/ajcn.2008.26615","volume":"89","author":"SJ James","year":"2009","unstructured":"James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O et al. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 2009; 89: 425\u2013430.","journal-title":"Am J Clin Nutr"},{"key":"BFmp2011165_CR73","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0278-5846(93)90058-Z","volume":"17","author":"MC Dolske","year":"1993","unstructured":"Dolske MC, Spollen J, McKay S, Lancashire E, Tolbert L . A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17: 765\u2013774.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp2011165_CR74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/13590840600681827","volume":"15","author":"M Boris","year":"2005","unstructured":"Boris M, Goldblatt A, Edelson SM . Improvement in children with autism treated with intravenous gamma globulin. J Nutritional Environmental Medicine 2005; 15: 169\u2013176.","journal-title":"J Nutritional Environmental Medicine"},{"key":"BFmp2011165_CR75","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6904-9-16","volume":"9","author":"JB Adams","year":"2009","unstructured":"Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A--medical results. BMC Clin Pharmacol 2009; 9: 16.","journal-title":"BMC Clin Pharmacol"},{"key":"BFmp2011165_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1472-6904-9-17","volume":"9","author":"JB Adams","year":"2009","unstructured":"Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. BMC Clin Pharmacol 2009; 9: 17.","journal-title":"BMC Clin Pharmacol"},{"key":"BFmp2011165_CR77","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/acm.2009.0177","volume":"16","author":"K Bertoglio","year":"2010","unstructured":"Bertoglio K, Jill James S, Deprey L, Brule N, Hendren RL . Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. J Altern Complement Med 2010; 16: 555\u2013560.","journal-title":"J Altern Complement Med"},{"key":"BFmp2011165_CR78","first-page":"42","volume":"14","author":"NH O\u2019Hara","year":"2008","unstructured":"O\u2019Hara NH, Szakacs GM . The recovery of a child with autism spectrum disorder through biomedical interventions. Altern Ther Health Med 2008; 14: 42\u201344.","journal-title":"Altern Ther Health Med"},{"key":"BFmp2011165_CR79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pnpbp.2009.09.012","volume":"34","author":"S Akhondzadeh","year":"2010","unstructured":"Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B et al. Double-blind placebo controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 32\u201336.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp2011165_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1742-2094-4-3","volume":"4","author":"M Boris","year":"2007","unstructured":"Boris M, Kaiser CC, Goldblatt A, Elice MW, Edelson SM, Adams JB et al. Effect of pioglitazone treatment on behavioral symptoms in autistic children. J Neuroinflammation 2007; 4: 3.","journal-title":"J Neuroinflammation"},{"key":"BFmp2011165_CR81","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0165-1781(95)02601-R","volume":"58","author":"MP Bouvard","year":"1995","unstructured":"Bouvard MP, Leboyer M, Launay JM, Recasens C, Plumet MH, Waller-Perotte D et al. Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study. Psychiatry Res 1995; 58: 191\u2013201.","journal-title":"Psychiatry Res"},{"key":"BFmp2011165_CR82","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.mehy.2006.10.015","volume":"68","author":"JJ Bradstreet","year":"2007","unstructured":"Bradstreet JJ, Smith S, Granpeesheh D, El-Dahr JM, Rossignol D . Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders. Med Hypotheses 2007; 68: 979\u2013987.","journal-title":"Med Hypotheses"},{"key":"BFmp2011165_CR83","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF02628672","volume":"9","author":"HH Fudenberg","year":"1996","unstructured":"Fudenberg HH . Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study. Biotherapy 1996; 9: 143\u2013147.","journal-title":"Biotherapy"},{"key":"BFmp2011165_CR84","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/088307389901400314","volume":"14","author":"S Gupta","year":"1999","unstructured":"Gupta S . Treatment of children with autism with intravenous immunoglobulin. J Child Neurol 1999; 14: 203\u2013205.","journal-title":"J Child Neurol"},{"key":"BFmp2011165_CR85","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1023\/A:1005568027292","volume":"30","author":"S Gupta","year":"2000","unstructured":"Gupta S . Immunological treatments for autism. J Autism Dev Disord 2000; 30: 475\u2013479.","journal-title":"J Autism Dev Disord"},{"key":"BFmp2011165_CR86","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/BF02172828","volume":"26","author":"S Gupta","year":"1996","unstructured":"Gupta S, Aggarwal S, Heads C . Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord 1996; 26: 439\u2013452.","journal-title":"J Autism Dev Disord"},{"key":"BFmp2011165_CR87","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/088307389601100622","volume":"11","author":"S Gupta","year":"1996","unstructured":"Gupta S, Rimland B, Shilling PD . Pentoxifylline: brief review and rationale for its possible use in the treatment of autism. J Child Neurol 1996; 11: 501\u2013504.","journal-title":"J Child Neurol"},{"key":"BFmp2011165_CR88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2431-7-36","volume":"7","author":"DA Rossignol","year":"2007","unstructured":"Rossignol DA, Rossignol LW, James SJ, Melnyk S, Mumper E . The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study. BMC Pediatr 2007; 7: 36.","journal-title":"BMC Pediatr"},{"key":"BFmp2011165_CR89","first-page":"351","volume":"32","author":"R Scifo","year":"1996","unstructured":"Scifo R, Cioni M, Nicolosi A, Batticane N, Tirolo C, Testa N et al. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Ann Ist Super Sanita 1996; 32: 351\u2013359.","journal-title":"Ann Ist Super Sanita"},{"key":"BFmp2011165_CR90","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1067\/mpd.2000.105355","volume":"136","author":"S Shenoy","year":"2000","unstructured":"Shenoy S, Arnold S, Chatila T . Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome. J Pediatr 2000; 136: 682\u2013687.","journal-title":"J Pediatr"},{"key":"BFmp2011165_CR91","first-page":"76","volume":"8","author":"JJ Bradstreet","year":"2003","unstructured":"Bradstreet JJ, Geier DA, Kartzinel JJ, Adams JB, Geier MR . A case-control study of mercury burden in children with autistic spectrum disorders. J Amer Physicians Surg 2003; 8: 76\u201379.","journal-title":"J Amer Physicians Surg"},{"key":"BFmp2011165_CR92","first-page":"303","volume":"23","author":"D Lonsdale","year":"2002","unstructured":"Lonsdale D, Shamberger RJ, Audhya T . Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuro Endocrinol Lett 2002; 23: 303\u2013308.","journal-title":"Neuro Endocrinol Lett"},{"key":"BFmp2011165_CR93","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1089\/acm.2007.0611","volume":"13","author":"K Patel","year":"2007","unstructured":"Patel K, Curtis LT . A comprehensive approach to treating autism and attention-deficit hyperactivity disorder: a prepilot study. J Altern Complement Med 2007; 13: 1091\u20131097.","journal-title":"J Altern Complement Med"},{"key":"BFmp2011165_CR94","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.nurt.2010.05.011","volume":"7","author":"S Bent","year":"2010","unstructured":"Bent S, Hendren RL . Improving the prediction of response to therapy in autism. Neurotherapeutics 2010; 7: 232\u2013240.","journal-title":"Neurotherapeutics"},{"key":"BFmp2011165_CR95","first-page":"15","volume":"15","author":"JJ Bradstreet","year":"2010","unstructured":"Bradstreet JJ, Smith S, Baral M, Rossignol DA . Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. Altern Med Rev 2010; 15: 15\u201332.","journal-title":"Altern Med Rev"},{"key":"BFmp2011165_CR96","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.clinbiochem.2009.03.011","volume":"42","author":"Y Al-Gadani","year":"2009","unstructured":"Al-Gadani Y, El-Ansary A, Attas O, Al-Ayadhi L . Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem 2009; 42: 1032\u20131040.","journal-title":"Clin Biochem"},{"key":"BFmp2011165_CR97","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.clinbiochem.2009.04.006","volume":"42","author":"OA Al-Mosalem","year":"2009","unstructured":"Al-Mosalem OA, El-Ansary A, Attas O, Al-Ayadhi L . Metabolic biomarkers related to energy metabolism in Saudi autistic children. Clin Biochem 2009; 42: 949\u2013957.","journal-title":"Clin Biochem"},{"key":"BFmp2011165_CR98","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/13547500902783747","volume":"14","author":"S Faber","year":"2009","unstructured":"Faber S, Zinn GM, Kern II JC, Kingston HM . The plasma zinc\/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 2009; 14: 171\u2013180.","journal-title":"Biomarkers"},{"key":"BFmp2011165_CR99","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1080\/15287390701457712","volume":"70","author":"DA Geier","year":"2007","unstructured":"Geier DA, Geier MR . A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health A 2007; 70: 1723\u20131730.","journal-title":"J Toxicol Environ Health A"},{"key":"BFmp2011165_CR100","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11064-008-9782-x","volume":"34","author":"DA Geier","year":"2009","unstructured":"Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR . A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 2009; 34: 386\u2013393.","journal-title":"Neurochem Res"},{"key":"BFmp2011165_CR101","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jns.2008.08.021","volume":"280","author":"DA Geier","year":"2009","unstructured":"Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R et al. Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci 2009; 280: 101\u2013108.","journal-title":"J Neurol Sci"},{"key":"BFmp2011165_CR102","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1442-200X.2010.03196.x","volume":"53","author":"JK Kern","year":"2011","unstructured":"Kern JK, Geier DA, Adams JB, Mehta JA, Grannemann BD, Geier MR . Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins. Pediatr Int 2011; 53: 147\u2013153.","journal-title":"Pediatr Int"},{"key":"BFmp2011165_CR103","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.mehy.2009.06.032","volume":"73","author":"RL Hendren","year":"2009","unstructured":"Hendren RL, Bertoglio K, Ashwood P, Sharp F . Mechanistic biomarkers for autism treatment. Med Hypotheses 2009; 73: 950\u2013954.","journal-title":"Med Hypotheses"},{"key":"BFmp2011165_CR104","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2431-9-21","volume":"9","author":"DA Rossignol","year":"2009","unstructured":"Rossignol DA, Rossignol LW, Smith S, Schneider C, Logerquist S, Usman A et al. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr 2009; 9: 21.","journal-title":"BMC Pediatr"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2011165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2011165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2011165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T09:38:35Z","timestamp":1686476315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2011165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFmp2011165"],"URL":"https:\/\/doi.org\/10.1038\/mp.2011.165","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,6]]}}}